INTRODUCTION
The Midwest Discussion Group of the Society of Toxicologic Pathologists met in Kalamazoo, Michigan, on April 14, 1993. The meeting was sponsored by The Upjohn Company at the Radisson Plaza Hotel. The topic for this meeting was &dquo;Techniques in the Assessment of Renal Toxicity.&dquo; Presentations covered a wide range of topics including kidney slice techniques, toxicity of glutathione and cysteine conjugates, renal blood flow and glomerular filtration measurement, renal protein, an overview of histopathology, and renal toxicity considerations in the development of biotechnology products. Selected abstracts of the presentations follow.
The kidney plays a key role in the conservation of proteins (1) . The negatively charged glomerular barrier sterically prevents the free passage of proteins with a molecular weight greater than 68 kDa. Negatively charged proteins such as albumin are electrostatically retained. Lower molecular weight proteins such as retinol binding protein and cx 1 microglobulin freely pass through the glomerular barrier but are reabsorbed by the proximal tubules. Injury to the glomerular barrier results in an increase in high molecular weight (HMW) proteins, whereas damage to the proximal tubules results in an in-crease in low molecular weight (LMW) proteins (3) . Other factors such as glomerular filtration rate and renal blood flow contribute to the regulation of proteins in the urine. Sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) allows for the rapid and accurate determination of molecular weight for proteins in the urine.
Treatment of rats with gentamicin results in the secretion of LMW proteins in the urine. The use of SDS-PAGE detected renal tubular injury at a dose of 6 mg/kg after 2 days of dosing, whereas N-acetyl-0-glucosaminidase (NAG) was elevated at a dose of 63 mg/kg. The increase in LMW renal proteins correlated with the presence of renal tubular necrosis (2) . D-ormaplatin produced dose-related renal papillary necrosis when given intravenously to Fischer-344 rats at doses of 2, 4, and 9 mg/kg. The morphologic lesions were most severe at 4 days postdosing and had repaired by day 9 in the 2-and 4-mg/kg dose groups. Blood urea nitrogen and NAG were slightly elevated at day 4 while creatinine clearance was decreased. The evaluation of urinary proteins by SDS-PAGE revealed an increase, primarily in HMW proteins at 4 days postdosing, indicating an increase in glomerular filtration of albumin and transferrin. The morphologic appearance of the glo-meruli was normal by light microscopy. LMW proteins were elevated to a lesser degree than HMW proteins. This correlated with a small increase in NAG seen at day 4 postdosing and the morphologic appearance of the kidney, indicating that the proximal tubules were affected but were not a major site of toxicity. Although the change in urinary proteins occurred at the same time as morphologic alterations in the renal papilla, these findings were not considered to be related.
SDS-PAGE provided a useful method for detecting and localizing renal toxicity when used in conjunction with morphologic and clinical chemistry methods. The kidney is an organ that performs many complex and diverse functions such as filtration, reabsorption, secretion of solutes, and production of concentrated urine, for the sole purpose of maintaining homeostasis. The renal tissue of humans, which totals 0.4% of body weight, receives 25% of the cardiac output. The kidney has a high compensatory action. Because the kidney has such high reserve, elevated changes in endogenous renal function tests (blood urea nitrogen and creatinine) are only seen after there is a vast reduction in nephron number. Measurement of glomerular filtration rate (GFR), using exogenous markers, is the best method for determining alteration in renal function ensuing from a change in nephron number. The accurate evaluation of GFR and renal blood flow (RBF) is of utmost importance when these measurements are correlated with morphological changes. These measurements are imperative and can be used to assist physicians, physiologists, pharmacologists, and toxicologists in delineating between physiological al-terations and pharmacologic effect, which in turn can be used to interpret toxicity of xenobiotics. In measuring these parameters, it is essential that the method for determination be non-invasive and safe, eliminating any undue risks and intricate processes. Radioactive iothalamate and p-aminohippuric acid (PAH) are accepted markers for measuring GFR and RBF, respectively. Their problems are those of risk of radiation exposure of the scientist and disposal of radioactive waste. A micro reverse-phase highperformance liquid chromatographic (HPLC) method was developed to simultaneously measure nonradioactive iothalamate and PAH in serum and urine using p-aminobenzoic acid (PABA) as an internal standard. Iothalamate was used in estimating GFR, while PAH was used in estimating effective RBF.
The simultaneous clearances of iothalamate and PAH were determined at a steady-state plasma level (22 pg/min) following an intravenous infusion rate of 0.1 ml/min. Samples were deproteinized with 2 volumes of acetonitrile and centrifuged. Five mi-croliters of deprotonized supernatant were injected onto a C 18 reverse-phase column. The mobile phase was comprised of tetrabutylammonium phosphate (1.2 mM) in sodium phosphate (0.1 M) buffer and methanol (85 parts: 15 parts, v/v). The flow rate was set at 1.0 ml/min, while column effluent was analyzed by ultraviolet detection (254 nm) with absorbance units full scale set at 0.032 for serum determinations and 0.064 for urine determinations.
Retention times for PAH, iothalamate, and PABA were 6.1, 8.3, and 14.6 min, respectively. This method requires as little as 5 >1 of sample and can be used to measure accurately down to 1.2 p,g iothal-amate and 0.6 gg PAH in serum and to 3.1 p,g iothalamate and 1.2 Ag PAH in urine. There was a 93.5 and 100% recovery of iothalamate in urine and serum, respectively. While PAH had a 92.6 and 99.8% recovery in urine and serum, respectively, there was no interference from endogenous substances.
The present study demonstrates that nonradioactive iothalamate and PAH could be measured simultaneously using a micro HPLC assay in the male rat for GFR and RBF measures. This method is a promising alternative for future GFR and RBF determinations.
Kidney Slice Techniques: Use of Renal Slices in Toxicology Grushenka H. I. Wolfgang Pathology and Experimental Toxicology, Parke-Davis Pharmaceutical Research, Division of Wamer-Lambert Company
Improved methods for preparing and culturing kidney slices have led to the increased use of slices as an in vitro model for investigating nephrotoxicity.
Using a mechanical slicer (1), slices of uniform diameter, thickness, and weight can be prepared rapidly and under more physiological conditions than with previous slicing methods.
To prepare renal slices by this method, cylindrical cores (6 mm in diameter) are cut through the kidney along the cortico-papillary axis (2) . Cores are then sliced perpendicular to this axis using the mechanical slicer to obtain slices approximately 250-300 Am thick. Cores are cut and slices are automatically collected in cold oxygenated Krebs-HEPES buffer, pH 7.4. Slices are then incubated in a nutrient medium such as DMEIF 12 at room temperature or 37°C for a designated time period. Slices have been shown to maintain viability for at least 24 hr in culture. Unlike cell or tubule isolation techniques, this technique is simple, fast, and easily transferable among species.
By orienting the cores prior to slicing, renal slices can be obtained from all 4 regions of the kidney (cortex, outer stripe, inner stripe, and medulla). Because the proximal tubule is the most common target of nephrotoxins, cortical slices have been characterized most thoroughly of the 4. Although cortical slices contain a mixed cell population (collecting ducts, glomeruli, proximal convoluted tubules, proximal straight tubules, and ascending thick segments), cells are maintained in their original tissue matrix in contrast to isolated tubules or primary cell cultures. Sufficient cortical slices are obtained from a single rabbit or 2 rats (60-100 slices) to perform a complete concentration-and time-response experiment.
Site-specific injury to the SIS2 versus S3 segments of the proximal tubule has been demonstrated histologically in cortical slices with model nephrotoxins that act at these sites in vivo (3) . A brief list of some of the compounds that have been tested in this system and demonstrate site-specific injury consistent with their in vivo activity include mercuric chloride, potassium dichromate, cisplatin, cephaloridine, gentamicin, hexachlorobutadiene, and dichlorovinylcysteine.
A battery of assays have been developed for assessing the toxicity of an agent in slices (4) . Commonly used biochemical assays include loss of intracellular potassium content and lactate dehydrogenase activity, and decreased oxygen consumption, ATP content and protein synthesis. Although slices are relatively similar in size and weight, biochemical data are usually normalized to protein or DNA content of the individual slice. Assays, more specifically targeted to assess functions of kidney cells, include organic anion and cation transport, gluconeogenesis, and glucose transport. The ability to perform histological evaluation and assess sitespecific lesions is a hallmark of the positional renal slice model. In addition to standard light microscopy and electron microscopy to describe site-specific lesions, autoradiography and x-ray microanalysis can be used to localize compounds within individual segments or subcellular components. Enzyme activities of biotransforming enzymes such as cysteine conjugate (3-lyase and cytochrome P-450 are maintained in renal cortical slices. Studies with selective enzyme inducers and/or inhibitors can be conducted to determine the role of biotransformation in causing nephrotoxicity.
The ability to culture slices for longer time periods (days) has been assisted by the development of an autoclavable tissue slicer and further improvements in culture methods. Longer term cultures will allow studies of low-dose, chronic injury as well as the performance of recovery/regeneration experiments. As with any in vitro system, renal slices should be selected for use after weighing the advantages and disadvantages of the system. Nonetheless, evidence over the past decade has shown that renal slices can be used as a simple, effective tool for establishing dose-response relationships, localizing the site of injury, and conducting mechanistic studies. Considering the ease of the slice technique and the increasing availability of human tissue for research, this in vitro model should prove to be a valuable tool in evaluating the nephrotoxic potential of compounds in human tissue.
